{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T21:49:17Z","timestamp":1778708957303,"version":"3.51.4"},"reference-count":32,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2012,3,29]],"date-time":"2012-03-29T00:00:00Z","timestamp":1332979200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0033692","type":"journal-article","created":{"date-parts":[[2012,3,29]],"date-time":"2012-03-29T21:21:38Z","timestamp":1333056098000},"page":"e33692","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":24,"title":["Achieving Secondary Prevention Low-Density Lipoprotein Particle Concentration Goals Using Lipoprotein Cholesterol-Based Data"],"prefix":"10.1371","volume":"7","author":[{"given":"Simon C.","family":"Mathews","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaya","family":"Mallidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krishnaji","family":"Kulkarni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter P.","family":"Toth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven R.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2012,3,29]]},"reference":[{"key":"ref1","first-page":"3143","article-title":"Third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) final report.","volume":"2002;106","journal-title":"Circulation"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.jacl.2007.10.001","article-title":"LDL particle number and risk of future cardiovascular disease in the framingham offspring study - implications for LDL management.","volume":"1","author":"WC Cromwell","year":"2007","journal-title":"J Clin Lipidol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.jacc.2006.09.043","article-title":"Value of low-density lipoprotein particle number and size as predictors of coronary artery disease in apparently healthy men and women: The EPIC-norfolk prospective population study.","volume":"49","author":"K El Harchaoui","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1161\/CIRCULATIONAHA.105.565135","article-title":"Low-density lipoprotein and high-density lipoprotein particle subclasses predict coronary events and are favorably changed by gemfibrozil therapy in the veterans affairs high-density lipoprotein intervention trial.","volume":"113","author":"JD Otvos","year":"2006","journal-title":"Circulation"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1161\/CIRCULATIONAHA.108.816181","article-title":"Lipoprotein particle profiles by nuclear magnetic resonance compared with standard lipids and apolipoproteins in predicting incident cardiovascular disease in women.","volume":"119","author":"S Mora","year":"2009","journal-title":"Circulation"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1161\/01.ATV.0000022015.97341.3A","article-title":"Nuclear magnetic resonance spectroscopy of lipoproteins and risk of coronary heart disease in the cardiovascular health study.","volume":"22","author":"L Kuller","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1161\/01.CIR.0000033222.75187.B9","article-title":"Low-density lipoprotein particle concentration and size as determined by nuclear magnetic resonance spectroscopy as predictors of cardiovascular disease in women.","volume":"106","author":"GJ Blake","year":"2002","journal-title":"Circulation"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0002-9149(02)02427-X","article-title":"Relations of lipoprotein subclass levels and low-density lipoprotein size to progression of coronary artery disease in the pravastatin limitation of atherosclerosis in the coronary arteries (PLAC-I) trial.","volume":"90","author":"RS Rosenson","year":"2002","journal-title":"Am J Cardiol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1373\/clinchem.2008.118356","article-title":"Apolipoprotein B and cardiovascular disease risk: Position statement from the AACC lipoproteins and vascular diseases division working group on best practices.","volume":"55","author":"JH Contois","year":"2009","journal-title":"Clin Chem"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1365-2796.2006.01616.x","article-title":"Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: Report of the thirty-person\/ten-country panel.","volume":"259","author":"PJ Barter","year":"2006","journal-title":"J Intern Med"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1016\/j.jacc.2008.02.034","article-title":"Lipoprotein management in patients with cardiometabolic risk: Consensus conference report from the american diabetes association and the american college of cardiology foundation.","volume":"51","author":"JD Brunzell","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1161\/01.CIR.0000133317.49796.0E","article-title":"Implications of recent clinical trials for the national cholesterol education program adult treatment panel III guidelines.","volume":"110","author":"SM Grundy","year":"2004","journal-title":"Circulation"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.atherosclerosis.2006.05.007","article-title":"LDL particle subclasses, LDL particle size, and carotid atherosclerosis in the multi-ethnic study of atherosclerosis (MESA).","volume":"192","author":"S Mora","year":"2007","journal-title":"Atherosclerosis"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"802","DOI":"10.7326\/0003-4819-139-10-200311180-00007","article-title":"Use of metabolic markers to identify overweight individuals who are insulin resistant.","volume":"139","author":"T McLaughlin","year":"2003","journal-title":"Ann Intern Med"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.2337\/diacare.23.11.1679","article-title":"Ratio of triglycerides to HDL cholesterol is an indicator of LDL particle size in patients with type 2 diabetes and normal HDL cholesterol levels.","volume":"23","author":"R Boizel","year":"2000","journal-title":"Diabetes Care"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0022-2275(20)40123-3","article-title":"Quantification of cholesterol in all lipoprotein classes by the VAP-II method.","volume":"35","author":"KR Kulkarni","year":"1994","journal-title":"J Lipid Res"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.cll.2006.07.004","article-title":"Cholesterol profile measurement by vertical auto profile method.","volume":"26","author":"KR Kulkarni","year":"2006","journal-title":"Clin Lab Med"},{"key":"ref18","first-page":"171","article-title":"Measurement of lipoprotein subclass profiles by nuclear magnetic resonance spectroscopy.","volume":"48","author":"JD Otvos","year":"2002","journal-title":"Clin Lab"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"22i","DOI":"10.1016\/S0002-9149(02)02632-2","article-title":"Measurement issues related to lipoprotein heterogeneity.","volume":"90","author":"JD Otvos","year":"2002","journal-title":"Am J Cardiol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.cll.2006.07.006","article-title":"Lipoprotein particle analysis by nuclear magnetic resonance spectroscopy.","volume":"26","author":"EJ Jeyarajah","year":"2006","journal-title":"Clin Lab Med"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1007\/s11886-009-0067-z","article-title":"Low-density lipoprotein and apolipoprotein B: Clinical use in patients with coronary heart disease.","volume":"11","author":"WC Cromwell","year":"2009","journal-title":"Curr Cardiol Rep"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1016\/j.amjcard.2006.07.036","article-title":"Heterogeneity of low-density lipoprotein particle number in patients with type 2 diabetes mellitus and low-density lipoprotein cholesterol <100 mg\/dl.","volume":"98","author":"WC Cromwell","year":"2006","journal-title":"Am J Cardiol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jacl.2007.12.006","article-title":"Differential response of cholesterol and particle measures of atherogenic lipoproteins to LDL-lowering therapy: Implications for clinical practice.","volume":"2","author":"A Sniderman","year":"2008","journal-title":"J Clin Lipidol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0021-9150(96)05802-9","article-title":"Transfer of low density lipoprotein into the arterial wall and risk of atherosclerosis.","volume":"123","author":"LB Nielsen","year":"1996","journal-title":"Atherosclerosis"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1161\/CIRCULATIONAHA.106.676890","article-title":"Subendothelial lipoprotein retention as the initiating process in atherosclerosis: Update and therapeutic implications.","volume":"116","author":"I Tabas","year":"2007","journal-title":"Circulation"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1016\/j.jacc.2004.03.046","article-title":"Optimal low-density lipoprotein is 50 to 70 mg\/dl: Lower is better and physiologically normal.","volume":"43","author":"JH O'Keefe Jr","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1056\/NEJMoa040583","article-title":"Intensive versus moderate lipid lowering with statins after acute coronary syndromes.","volume":"350","author":"CP Cannon","year":"2004","journal-title":"N Engl J Med"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1056\/NEJMoa050461","article-title":"Intensive lipid lowering with atorvastatin in patients with stable coronary disease.","volume":"352","author":"JC LaRosa","year":"2005","journal-title":"N Engl J Med"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S0828-282X(06)70310-5","article-title":"Canadian cardiovascular society position statement\u2013recommendations for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease.","volume":"22","author":"R McPherson","year":"2006","journal-title":"Can J Cardiol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1001\/jama.1996.03540110029028","article-title":"Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women.","volume":"276","author":"CD Gardner","year":"1996","journal-title":"JAMA"},{"key":"ref31","first-page":"859","article-title":"A prospective, population-based study of low density lipoprotein particle size as a risk factor for ischemic heart disease in men.","volume":"17","author":"B Lamarche","year":"2001","journal-title":"Can J Cardiol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1161\/01.ATV.0000154144.73236.f4","article-title":"Low-density lipoprotein subfractions and the long-term risk of ischemic heart disease in men: 13-year follow-up data from the quebec cardiovascular study.","volume":"25","author":"AC St-Pierre","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0033692","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,8]],"date-time":"2022-01-08T21:54:45Z","timestamp":1641678885000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0033692"}},"subtitle":[],"editor":[{"given":"Guoying","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2012,3,29]]},"references-count":32,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2012,3,29]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0033692","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,29]]}}}